AAL vs HBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 20, 2026

AAL

50.6
AI Score
VS
AAL Wins

HBIO

40.8
AI Score

Investment Advisor Scores

AAL

51score
Recommendation
HOLD

HBIO

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AAL HBIO Winner
Forward P/E 45.045 15.0602 HBIO
PEG Ratio 0.8007 1.3059 AAL
Revenue Growth 16.3% 11.1% AAL
Earnings Growth -88.2% -80.3% HBIO
Tradestie Score 50.6/100 40.8/100 AAL
Profit Margin -0.6% -11.9% AAL
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

AAL 1M: +2.0% · 3M: +1.7% HBIO 1M: +20.8% · 3M: +35.5%

Current Technical Phase

AAL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 38.1 · Price: $13.82

HBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.3% over 20 days), RSI 71

RSI (14): 71.1 · Price: $7.48

Fundamentals Snapshot

Metric AAL HBIO
Market Cap
Forward P/E 5.7 11.6
Trailing P/E
Revenue (TTM)
Revenue Growth 0.2% 0.1%
Gross Margin 0.2% 0.6%
Operating Margin 0.0% 0.0%
EPS -0.49 -2.30
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, AAL is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.